Description: This study will evaluate an investigational drug for people with multiple sclerosis who have cognitive impairment. Participants will be required to visit the clinic approximately six times over three months. Candidates must be 18 to 64 with at least a 9th grade education and a diagnosis of MS (relapsing remitting or secondary progressive). Additional criteria apply.